Molina director granted 237 MOH shares in equity award

BRASIER BARBARA L reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

BRASIER BARBARA L reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare, Inc. director Barbara L. Brasier received a grant of 237 shares of common stock as part of her director compensation. The shares were granted under the company’s 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.

The award represents one quarterly installment of a $220,000 annual equity award for each director, with this quarter’s portion set at $55,000. Following this grant, Brasier directly holds 5,818 shares of Molina Healthcare common stock, reflecting routine, compensation-related equity ownership rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 237 shares

Grant/Award 1 txn

Insider BRASIER BARBARA L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 5,818 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.
3. F3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Key Figures

Shares granted: 237 shares Grant price per share: $232.55 per share Quarterly equity value: $55,000 +2 more

5 metrics

Shares granted 237 shares Quarterly equity grant to director on July 1, 2026

Grant price per share $232.55 per share Closing price of common stock on July 1, 2026

Quarterly equity value $55,000 One quarter of annual director equity award

Annual director equity award $220,000 Aggregate dollar value of each director’s annual equity award

Shares owned after grant 5,818 shares Director’s direct holdings following the July 1, 2026 grant

Key Terms

2025 Equity Incentive Plan, annual equity award, closing price

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

closing price financial

"The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Molina Healthcare (MOH) report for Barbara L. Brasier?

Molina Healthcare reported that director Barbara L. Brasier received a grant of 237 common shares. The grant is a scheduled equity award under the 2025 Equity Incentive Plan, tied to her ongoing services as a director and not an open-market transaction.

How was the number of shares in Barbara Brasier’s Molina Healthcare (MOH) grant determined?

The 237-share grant was based on a $55,000 quarterly equity value divided by the July 1, 2026 closing price of $232.55. This quarterly grant is one quarter of a $220,000 annual equity award set for each Molina Healthcare director.

What is the total annual equity award for Molina Healthcare (MOH) directors?

Each Molina Healthcare director has an annual equity award set at $220,000. This amount is delivered in four equal quarterly grants of $55,000 each, calculated using the company’s common stock closing price on the first day of each quarter.

What is Barbara Brasier’s Molina Healthcare (MOH) shareholding after the latest grant?

After receiving the 237-share equity grant, Barbara L. Brasier directly holds 5,818 shares of Molina Healthcare common stock. This updated holding reflects only her direct ownership position reported in the filing and results from routine, compensation-related stock awards.

Was Barbara Brasier’s Molina Healthcare (MOH) transaction an open-market buy or sell?

No, the transaction was not an open-market buy or sell. It was coded as a grant or award acquisition, representing stock granted under Molina Healthcare’s 2025 Equity Incentive Plan in connection with Brasier’s service as a director, rather than a discretionary market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRASIER BARBARA L

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		237(2)	A	$232.55(3)	5,818	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Remarks:

	Jeff D. Barlow, by power of attorney for Barbara L. Brasier	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)